Paclitaxel, uracil plus tegafur (UFT) and leucovorin (LV) in patients with pre-treated metastatic breast cancer: Preclinical rationale and phase I study results

被引：0
|
作者：
Passardi, A. [1 ]
Massa, I. [1 ]
Milandri, C. [1 ]
Cecconetto, L. [1 ]
Calpona, S. [1 ]
Ibrahim, T. [1 ]
Ridolfi, L. [1 ]
Zoli, W. [1 ]
Frassineti, L. [1 ]
Maltoni, R. [1 ]
机构：
[1] Ist Oncol Romagnolo, Forll, Italy
来源：
ANNALS OF ONCOLOGY | 2006年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：XI11 / XI12
页数：2
相关论文
共 50 条
  • [31] A phase I study of paclitaxel, carboplatin, and the combination of uracil plus tegafur in a single capsule with oral leucovorin in patients with advanced upper gastrointestinal carcinomas
    Ajani, JA
    Hargraves, K
    Fairweather, J
    Humphrey, J
    SEMINARS IN ONCOLOGY, 1999, 26 (06) : 57 - 57
  • [32] A phase I dose-finding trial of UFT/leucovorin (LV) in combination with vinorelbine (VNB) in patients with metastatic breast cancer (MBC).
    Fumoleau, P
    Bonneterre, J
    Kerbrat, P
    Fargeot, P
    Déporte-Féty, R
    Garet, F
    ANNALS OF ONCOLOGY, 2000, 11 : 32 - 33
  • [33] A phase I study of UFT/leucovorin (LV), carboplatin and paclitaxel with external beam radiation therapy (EBRT) for patients with esophageal cancer (EC)
    Czito, B.
    Bendell, J.
    Willett, C.
    Kelsev, C.
    Morse, M.
    D'Amico, T.
    Hurwitz, H.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S288 - S289
  • [34] Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial
    Sibylle Loibl
    Caroline Murmann
    Katrin Schwedler
    Mathias Warm
    Lothar Müller
    Georg Heinrich
    Valentina Nekljudova
    Gunter von Minckwitz
    Cancer Chemotherapy and Pharmacology, 2009, 63
  • [35] Phase I dose finding study evaluating the combination of bendamustine with weekly paclitaxel in patients with pre-treated metastatic breast cancer: RiTa trial
    Loibl, Sibylle
    Murmann, Caroline
    Schwedler, Katrin
    Warm, Mathias
    Mueller, Lothar
    Heinrich, Georg
    Nekljudova, Valentina
    von Minckwitz, Gunter
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 63 (05) : 953 - 958
  • [36] A phase I study -: UFT/leucovorin combined with paclitaxel for anthracycline-pretreated advanced breast cancer
    Scholz, U
    Lück, HJ
    Canzler, U
    Robner, D
    Kühnle, H
    ONCOLOGY-NEW YORK, 2000, 14 (10): : 44 - 46
  • [37] Appropriate schedule of oral tegafur / uracil (UFT) in combination with irinotecan (CPT-11) and bolus 5-FU / l-leucovorin (LV) in patients (pts) with metastatic colorectal cancer (MCRC): A phase I study
    Chayahara, N.
    Tamura, T.
    Miki, I.
    Okuno, T.
    Kamigaki, T.
    Nishisaki, H.
    Inoue, Y.
    Maeda, T.
    Sakaeda, T.
    Azuma, T.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [38] Phase I trial of uracil-tegafur, leucovorin, and etoposide: An active all oral regimen for metastatic breast cancer.
    Hartman, AR
    Grekowicz, A
    Lum, BL
    Carlson, RW
    Sikic, BI
    Shapiro, R
    Stockdale, FE
    JOURNAL OF INVESTIGATIVE MEDICINE, 2003, 51 : S166 - S166
  • [39] Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
    Douillard, JY
    Hoff, PM
    Skillings, JR
    Eisenberg, P
    Davidson, N
    Harper, P
    Vincent, MD
    Lembersky, BC
    Thompson, S
    Maniero, A
    Benner, SE
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (17) : 3605 - 3616
  • [40] EFFICACY AND SAFETY OF A COMBINATION OF ESTRAMUSTINE, PACLITAXEL, AND UFT (TEGAFUR-URACIL) (ETU) IN PATIENTS WITH METASTATIC HORMONE-REFRACTORY PROSTATE CANCER (MHRPC): RESULTS OF A MULTICENTER PHASE II STUDY
    Fitoussi, O.
    Guichard, F.
    Hirt, S.
    Dohollou, N.
    Bureau, C.
    Audhuy, F.
    Guichard, P.
    ANNALS OF ONCOLOGY, 2008, 19 : 199 - 199
12345